TET2 c.1009G>T ;(p.E337*)

Variant ID: 4-106156108-G-T

NM_001127208.2(TET2):c.1009G>T;(p.E337*)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.

Nature Communications
Nagata, Yasunobu Y; Makishima, Hideki H; Kerr, Cassandra M CM; Przychodzen, Bartlomiej P BP; Aly, Mai M; Goyal, Abhinav A; Awada, Hassan H; Asad, Mohammad Fahad MF; Kuzmanovic, Teodora T; Suzuki, Hiromichi H; Yoshizato, Tetsuichi T; Yoshida, Kenichi K; Chiba, Kenichi K; Tanaka, Hiroko H; Shiraishi, Yuichi Y; Miyano, Satoru S; Mukherjee, Sudipto S; LaFramboise, Thomas T; Nazha, Aziz A; Sekeres, Mikkael A MA; Radivoyevitch, Tomas T; Haferlach, Torsten T; Ogawa, Seishi S; Maciejewski, Jaroslaw P JP
Publication Date: 2019-11-26

Variant appearance in text: TET2: E337X
PubMed Link: 31772163
Variant Present in the following documents:
  • 41467_2019_13001_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression.

Oncotarget
Marçais, Ambroise A; Waast, Laetitia L; Bruneau, Julie J; Hanssens, Katia K; Asnafi, Vahid V; Gaulard, Philippe P; Suarez, Felipe F; Dubreuil, Patrice P; Gessain, Antoine A; Hermine, Olivier O; Pique, Claudine C
Publication Date: 2017-08-08

Variant appearance in text: TET2: Glu337*
PubMed Link: 28881727
Variant Present in the following documents:
  • Main text
  • oncotarget-08-52256.pdf
View BVdb publication page